Literature DB >> 28355946

Dysexecutive Symptoms in Primary Progressive Aphasia: Beyond Diagnostic Criteria.

Joël Macoir1,2, Monica Lavoie1,2, Robert Laforce3,4, Simona M Brambati5, Maximiliano A Wilson1,2.   

Abstract

Primary progressive aphasia (PPA) is a heterogeneous neurodegenerative condition in which the most prominent clinical feature is language difficulties. Other cognitive domains have been described to remain unaffected at the early stages of the disease and, therefore, excluded from diagnostic criteria. However, we show in this article that executive function (EF) disorders may be present in the 3 variants (nonfluent/agrammatic, logopenic, and semantic) of PPA. We also illustrate changes in language and EF by means of a 3-year behavioral and neuroimaging longitudinal study of a patient suffering from the semantic variant of PPA. This review provides an update on current knowledge of PPA, suggesting that dysexecutive symptoms may be encountered in the 3 PPA variants, in their early phases and/or in more advanced stages, when atrophy extends to adjacent brain areas.

Entities:  

Keywords:  assessment; executive functions; language impairment; primary progressive aphasia

Mesh:

Year:  2017        PMID: 28355946     DOI: 10.1177/0891988717700507

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  8 in total

1.  Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint.

Authors:  Adam M Staffaroni; Lynn Bajorek; Kaitlin B Casaletto; Yann Cobigo; Sheng-Yang M Goh; Amy Wolf; Hilary W Heuer; Fanny M Elahi; Peter A Ljubenkov; Reilly Dever; John Kornak; Brian Appleby; Jessica Bove; Yvette Bordelon; Patrick Brannelly; Danielle Brushaber; Christina Caso; Giovanni Coppola; Christina Dheel; Bradford C Dickerson; Susan Dickinson; Sophia Dominguez; Kimiko Domoto-Reilly; Kelly Faber; Jessica Ferrall; Julie A Fields; Ann Fishman; Jamie Fong; Tatiana Foroud; Leah K Forsberg; Ralitza Gavrilova; Debra Gearhart; Behnaz Ghazanfari; Nupur Ghoshal; Jill Goldman; Jonathan Graff-Radford; Neill Graff-Radford; Ian Grant; Murray Grossman; Dana Haley; Ging-Yuek Hsiung; Edward D Huey; David J Irwin; David T Jones; Lynne Jones; Kejal Kantarci; Anna Karydas; Daniel I Kaufer; Diana R Kerwin; David S Knopman; Ruth Kraft; Walter K Kremers; Walter A Kukull; Irene Litvan; Diane Lucente; Codrin Lungu; Ian R Mackenzie; Miranda Maldonado; Masood Manoochehri; Scott M McGinnis; Emily McKinley; Mario F Mendez; Bruce L Miller; Namita Multani; Chiadi Onyike; Jaya Padmanabhan; Alex Pantelyat; Rodney Pearlman; Len Petrucelli; Madeline Potter; Rosa Rademakers; Eliana Marisa Ramos; Katherine P Rankin; Katya Rascovsky; Erik D Roberson; Emily Rogalski; Pheth Sengdy; Leslie M Shaw; Jeremy Syrjanen; M Carmela Tartaglia; Nadine Tatton; Joanne Taylor; Arthur Toga; John Q Trojanowski; Sandra Weintraub; Ping Wang; Bonnie Wong; Zbigniew Wszolek; Adam L Boxer; Brad F Boeve; Joel H Kramer; Howard J Rosen
Journal:  Alzheimers Dement       Date:  2019-05-11       Impact factor: 21.566

2.  One cat, Two cats, Red cat, Blue cats: Eliciting morphemes from individuals with primary progressive aphasia.

Authors:  Melissa D Stockbridge; William Matchin; Alexandra Walker; Bonnie Breining; Julius Fridriksson; Gregory Hickok; Argye E Hillis
Journal:  Aphasiology       Date:  2021-03-16       Impact factor: 2.773

3.  Functional Disabilities and Psychiatric Symptoms in Primary Progressive Aphasia.

Authors:  Christopher B Morrow; Jeannie-Marie Sheppard Leoutsakos; Chiadi U Onyike
Journal:  Am J Geriatr Psychiatry       Date:  2021-07-28       Impact factor: 7.996

4.  Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia.

Authors:  David Bergeron; Maria L Gorno-Tempini; Gil D Rabinovici; Miguel A Santos-Santos; William Seeley; Bruce L Miller; Yolande Pijnenburg; M Antoinette Keulen; Colin Groot; Bart N M van Berckel; Wiesje M van der Flier; Philip Scheltens; Jonathan D Rohrer; Jason D Warren; Jonathan M Schott; Nick C Fox; Raquel Sanchez-Valle; Oriol Grau-Rivera; Ellen Gelpi; Harro Seelaar; Janne M Papma; John C van Swieten; John R Hodges; Cristian E Leyton; Olivier Piguet; Emily J Rogalski; Marsel M Mesulam; Lejla Koric; Kristensen Nora; Jeéreémie Pariente; Bradford Dickerson; Ian R Mackenzie; Ging-Yuek R Hsiung; Serge Belliard; David J Irwin; David A Wolk; Murray Grossman; Matthew Jones; Jennifer Harris; David Mann; Julie S Snowden; Patricio Chrem-Mendez; Ismael L Calandri; Alejandra A Amengual; Carole Miguet-Alfonsi; Eloi Magnin; Giuseppe Magnani; Roberto Santangelo; Vincent Deramecourt; Florence Pasquier; Niklas Mattsson; Christer Nilsson; Oskar Hansson; Julia Keith; Mario Masellis; Sandra E Black; Jordi A Matías-Guiu; María-Nieves Cabrera-Martin; Claire Paquet; Julien Dumurgier; Marc Teichmann; Marie Sarazin; Michel Bottlaender; Bruno Dubois; Christopher C Rowe; Victor L Villemagne; Rik Vandenberghe; Elias Granadillo; Edmond Teng; Mario Mendez; Philipp T Meyer; Lars Frings; Alberto Lleó; Rafael Blesa; Juan Fortea; Sang Won Seo; Janine Diehl-Schmid; Timo Grimmer; Kristian Steen Frederiksen; Pascual Sánchez-Juan; Gaël Chételat; Willemijn Jansen; Rémi W Bouchard; Robert Jr Laforce; Pieter Jelle Visser; Rik Ossenkoppele
Journal:  Ann Neurol       Date:  2018-11       Impact factor: 10.422

5.  Visuomotor Figure Construction and Visual Figure Delayed Recall and Recognition in Primary Progressive Aphasia.

Authors:  Donna C Tippett; Bonnie Breining; Emily Goldberg; Erin Meier; Shannon M Sheppard; Emily Sherry; Melissa Stockbridge; Adrian Suarez; Amy E Wright; Argye E Hillis
Journal:  Aphasiology       Date:  2019-09-23       Impact factor: 2.773

6.  Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint.

Authors:  Adam M Staffaroni; Lynn Bajorek; Kaitlin B Casaletto; Yann Cobigo; Sheng-Yang M Goh; Amy Wolf; Hilary W Heuer; Fanny M Elahi; Peter A Ljubenkov; Reilly Dever; John Kornak; Brian Appleby; Jessica Bove; Yvette Bordelon; Patrick Brannelly; Danielle Brushaber; Christina Caso; Giovanni Coppola; Christina Dheel; Bradford C Dickerson; Susan Dickinson; Sophia Dominguez; Kimiko Domoto-Reilly; Kelly Faber; Jessica Ferrall; Julie A Fields; Ann Fishman; Jamie Fong; Tatiana Foroud; Leah K Forsberg; Ralitza Gavrilova; Debra Gearhart; Behnaz Ghazanfari; Nupur Ghoshal; Jill Goldman; Jonathan Graff-Radford; Neill Graff-Radford; Ian Grant; Murray Grossman; Dana Haley; Ging-Yuek Hsiung; Edward D Huey; David J Irwin; David T Jones; Lynne Jones; Kejal Kantarci; Anna Karydas; Daniel I Kaufer; Diana R Kerwin; David S Knopman; Ruth Kraft; Walter K Kremers; Walter A Kukull; Irene Litvan; Diane Lucente; Codrin Lungu; Ian R Mackenzie; Miranda Maldonado; Masood Manoochehri; Scott M McGinnis; Emily McKinley; Mario F Mendez; Bruce L Miller; Namita Multani; Chiadi Onyike; Jaya Padmanabhan; Alex Pantelyat; Rodney Pearlman; Len Petrucelli; Madeline Potter; Rosa Rademakers; Eliana Marisa Ramos; Katherine P Rankin; Katya Rascovsky; Erik D Roberson; Emily Rogalski; Pheth Sengdy; Leslie M Shaw; Jeremy Syrjanen; M Carmela Tartaglia; Nadine Tatton; Joanne Taylor; Arthur Toga; John Q Trojanowski; Sandra Weintraub; Ping Wang; Bonnie Wong; Zbigniew Wszolek; Adam L Boxer; Brad F Boeve; Joel H Kramer; Howard J Rosen
Journal:  Alzheimers Dement       Date:  2020-01       Impact factor: 21.566

7.  Utility of the Addenbrooke's Cognitive Examination III online calculator to differentiate the primary progressive aphasia variants.

Authors:  D Foxe; A Hu; S C Cheung; R M Ahmed; N J Cordato; E Devenney; Y T Hwang; G M Halliday; N Mueller; C E Leyton; J R Hodges; J R Burrell; M Irish; O Piguet
Journal:  Brain Commun       Date:  2022-07-07

Review 8.  Understanding the multidimensional cognitive deficits of logopenic variant primary progressive aphasia.

Authors:  Siddharth Ramanan; Muireann Irish; Karalyn Patterson; James B Rowe; Maria Luisa Gorno-Tempini; Matthew A Lambon Ralph
Journal:  Brain       Date:  2022-09-14       Impact factor: 15.255

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.